Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
3.
Dermatol Surg ; 47(7): 944-946, 2021 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-33731575

RESUMO

BACKGROUND: Croton oil (CO) is used by dermatologists and plastic surgeons in deep chemical peels. It is mixed with phenol, water, and a soap in Baker-Gordon's or Hetter's formulas. There is controversy as to whether CO or phenol is the active agent in the dermal effect of deep chemical peels. OBJECTIVE: To better clarify the role of CO in deep peels, by identification of active compounds in commercially available CO in the United States and biological effects in vivo. MATERIALS AND METHODS: Liquid chromatography-tandem mass spectrometry on CO and a domestic pig model experiment using 3 different formulas: G1: 5% Septisol (SEP), G2: 1.6% croton oil in 35% phenol with 5% SEP, and G3: 35% phenol with 5% SEP. RESULTS: Liquid chromatography-tandem mass spectrometry indicated the presence of phorbol esters. G1 was null overall. Extent of the coagulative necrosis: G2 > G3. Vascular ectasia: G2 > G3. Inflammation pattern: intense neutrophilic inflammatory band in G2 versus mild, sparse, perivascular mononuclear cell infiltrate in G3. Neocollagenesis: pronounced in G2, negligible in G3. CONCLUSION: Coagulative necrosis of the epidermis, superficial fibroblasts, and vasculature can be attributed to the action of phenol. Phorbol esters on CO could be responsible for the dense deep acute inflammation and the distinctive neocollagenesis.


Assuntos
Abrasão Química/métodos , Óleo de Cróton/farmacologia , Fármacos Dermatológicos/farmacologia , Fenóis/farmacologia , Animais , Feminino , Masculino , Suínos
4.
PLoS Negl Trop Dis ; 13(5): e0007405, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-31145746

RESUMO

BACKGROUND: Rickettsia bacteria are responsible for diseases in humans and animals around the world, however few details are available regarding its ecology and circulation among wild animals and human populations at high transmission risk in Brazil. The aim of this study was to investigate the occurrence of ticks and Rickettsia spp. in wild boars, corresponding hunting dogs and hunters. METHODS: Serum samples and ticks were collected from 80 free-range wild boars, 170 hunting dogs and 34 hunters from southern and central-western Brazil, from the Atlantic Forest and Cerrado biomes, respectively, between 2016 and 2018. Serum samples were tested by indirect immunofluorescent-antibody assay (IFA) to detect IgG antibodies against Rickettsia rickettsii, Rickettsia parkeri, Rickettsia bellii, Rickettsia rhipicephali and Rickettsia amblyommatis. Tick species were identified by morphological taxonomic keys, as previously described. A total of 164 ticks including A. sculptum, A. brasiliense and A. aureolatum were tested in PCR assays for Spotted Fever Group (SFG) Rickettsia spp. RESULTS: A total of 58/80 (72.5%) wild boars, 24/170 (14.1%) hunting dogs and 5/34 (14.7%) hunters were positive (titers ≥ 64) to at least one Rickettsia species. A total of 669/1,584 (42.2%) ticks from wild boars were identified as Amblyomma sculptum, 910/1,584 (57.4%) as Amblyomma brasiliense, 4/1,584(0.24%) larvae of Amblyomma spp. and 1/1,584 (0.06%) nymph as Amblyolmma dubitatum. All 9 ticks found on hunting dogs were identified as Amblyomma aureolatum and all 22 ticks on hunters as A. sculptum. No tested tick was positive by standard PCR to SFG Rickettsia spp. CONCLUSIONS: The present study was the concomitant report of wild boar, hunting dog and hunter exposure to SFG rickettsiae agents, performed in two different Brazilian biomes. Wild boar hunting may increase the risk of human exposure and consequently tick-borne disease Wild boars may be carrying and spreading capybara ticks from their original habitats to other ecosystems. Further studies can be required to explore the ability of wild boars to infecting ticks and be part of transmission cycle of Rickettsia spp.


Assuntos
Anticorpos Antibacterianos/sangue , Doenças do Cão/sangue , Cães/sangue , Infecções por Rickettsia/sangue , Infecções por Rickettsia/veterinária , Rickettsia/imunologia , Doenças dos Suínos/sangue , Carrapatos/imunologia , Animais , Animais Selvagens/sangue , Animais Selvagens/microbiologia , Brasil , Doenças do Cão/microbiologia , Cães/microbiologia , Feminino , Humanos , Masculino , Rickettsia/classificação , Rickettsia/isolamento & purificação , Infecções por Rickettsia/microbiologia , Sus scrofa/sangue , Sus scrofa/microbiologia , Suínos , Doenças dos Suínos/microbiologia , Carrapatos/classificação , Carrapatos/microbiologia
5.
J Biomater Appl ; 32(9): 1212-1221, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29380661

RESUMO

A new alginate dressing with Aloe vera gel was developed and used to study its cutaneous healing effect in vivo by surgical wounds in Wistar rats. The aloe-alginate film was characterized by Fourier-transform infrared spectroscopy, mechanical properties, scanning electron microscopy, hydration rate, and calcium release. The aloe-alginate film demonstrated desirable physical and mechanical characteristics for wound dressing application. The animals were divided in three groups (n = 20): gauze bandage, alginate film, and aloe-alginate film. The histological analysis on the 3rd, 7th, 14th, and 22nd days after the treatment showed that the aloe-alginate films modulated the inflammatory phase and decreased the quantity of macrophages when compared to the alginate film group and the control (gauze bandage). The evaluation of collagen fibers showed a decrease in type III and increase in type I fibers on group treated with aloe-alginate film suggesting an improvement in the progression of the healing process.


Assuntos
Alginatos/uso terapêutico , Bandagens , Preparações de Plantas/uso terapêutico , Cicatrização/efeitos dos fármacos , Alginatos/química , Aloe/química , Animais , Masculino , Preparações de Plantas/química , Ratos Wistar , Espectroscopia de Infravermelho com Transformada de Fourier , Água/química
6.
An Acad Bras Cienc ; 89(3): 1699-1705, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28876395

RESUMO

INTRODUCTION/AIM: The gut has shown to have a pivotal role on the pathophysiology of metabolic disease. Food stimulation of distal intestinal segments promotes enterohormones secretion influencing insulin metabolism. In diabetic rats, oral insulin has potential to change intestinal epithelium behavior. This macromolecule promotes positive effects on laboratorial metabolic parameters and decreases diabetic intestinal hypertrophy. This study aims to test if oral insulin can influence metabolic parameters and intestinal weight in obese non-diabetic rats. METHODS: Twelve weeks old Wistar rats were divided in 3 groups: control (CTRL) standard chow group; high fat diet low carbohydrates group (HFD) and HFD plus daily oral 20U insulin gavage (HFD+INS). Weight and food consumption were weekly obtained. After eight weeks, fasting blood samples were collected for laboratorial analysis. After euthanasia gut samples were isolated. RESULTS: Rat oral insulin treatment decreased body weight gain (p<0,001), fasting glucose and triglycerides serum levels (p<0,05) an increased intestinal weight of distal ileum (P<0,05). Animal submitted to high fat diet presented higher levels of HOMA-IR although significant difference to CT was not achieved. HOMA-beta were significantly higher (p<0.05) in HFD+INS. Visceral fat was 10% lower in HFD+INS but the difference was not significant. CONCLUSIONS: In non-diabetic obese rats, oral insulin improves metabolic malfunction associated to rescue of beta-cell activity.


Assuntos
Glicemia/análise , Dieta Hiperlipídica , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Lipídeos/sangue , Redução de Peso/efeitos dos fármacos , Animais , Glicemia/efeitos dos fármacos , Hipoglicemiantes/farmacologia , Insulina/farmacologia , Masculino , Radioimunoensaio , Ratos , Ratos Wistar
7.
An. acad. bras. ciênc ; 89(3): 1699-1705, July-Sept. 2017. graf
Artigo em Inglês | LILACS | ID: biblio-886771

RESUMO

ABSTRACT Introduction/Aim: The gut has shown to have a pivotal role on the pathophysiology of metabolic disease. Food stimulation of distal intestinal segments promotes enterohormones secretion influencing insulin metabolism. In diabetic rats, oral insulin has potential to change intestinal epithelium behavior. This macromolecule promotes positive effects on laboratorial metabolic parameters and decreases diabetic intestinal hypertrophy. This study aims to test if oral insulin can influence metabolic parameters and intestinal weight in obese non-diabetic rats. Methods: Twelve weeks old Wistar rats were divided in 3 groups: control (CTRL) standard chow group; high fat diet low carbohydrates group (HFD) and HFD plus daily oral 20U insulin gavage (HFD+INS). Weight and food consumption were weekly obtained. After eight weeks, fasting blood samples were collected for laboratorial analysis. After euthanasia gut samples were isolated. Results: Rat oral insulin treatment decreased body weight gain (p<0,001), fasting glucose and triglycerides serum levels (p<0,05) an increased intestinal weight of distal ileum (P<0,05). Animal submitted to high fat diet presented higher levels of HOMA-IR although significant difference to CT was not achieved. HOMA-beta were significantly higher (p<0.05) in HFD+INS. Visceral fat was 10% lower in HFD+INS but the difference was not significant. Conclusions: In non-diabetic obese rats, oral insulin improves metabolic malfunction associated to rescue of beta-cell activity.


Assuntos
Animais , Masculino , Ratos , Glicemia/análise , Redução de Peso/efeitos dos fármacos , Dieta Hiperlipídica , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Lipídeos/sangue , Glicemia/efeitos dos fármacos , Radioimunoensaio , Ratos Wistar , Hipoglicemiantes/farmacologia , Insulina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...